The Treat Trial-moving ST-elevation myocardial infarction care forward, with more to do

Clyde W. Yancy; Robert A. Harrington

doi:10.1001/jamacardio.2018.0612

The Treat Trial-moving ST-elevation myocardial infarction care forward, with more to do

Clyde W. Yancy^*, Robert A. Harrington

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	399-400
Number of pages	2
Journal	JAMA cardiology
Volume	3
Issue number	5
DOIs	https://doi.org/10.1001/jamacardio.2018.0612
State	Published - May 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2018.0612

Cite this

@article{36da7237a5ab4f18aa1ba70e77696240,

title = "The Treat Trial-moving ST-elevation myocardial infarction care forward, with more to do",

author = "Yancy, {Clyde W.} and Harrington, {Robert A.}",

note = "Funding Information: Dr Harrington reports receiving grants from Astra, Bristol-Myers Squibb, Janssen, Novartis, Portola, the Medicines Company, Sanofi, and CSL Limited; personal fees from Amgen, Bayer, Element Science, Gilead, MyoKardia, and the Medicines Company; and serving on the board of directors of the American Heart Association and Stanford Health Care. No disclosures were reported.",

year = "2018",

month = may,

doi = "10.1001/jamacardio.2018.0612",

language = "English (US)",

volume = "3",

pages = "399--400",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - The Treat Trial-moving ST-elevation myocardial infarction care forward, with more to do

AU - Yancy, Clyde W.

AU - Harrington, Robert A.

N1 - Funding Information: Dr Harrington reports receiving grants from Astra, Bristol-Myers Squibb, Janssen, Novartis, Portola, the Medicines Company, Sanofi, and CSL Limited; personal fees from Amgen, Bayer, Element Science, Gilead, MyoKardia, and the Medicines Company; and serving on the board of directors of the American Heart Association and Stanford Health Care. No disclosures were reported.

PY - 2018/5

Y1 - 2018/5

UR - http://www.scopus.com/inward/record.url?scp=85049083789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049083789&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2018.0612

DO - 10.1001/jamacardio.2018.0612

M3 - Editorial

C2 - 29525822

AN - SCOPUS:85049083789

VL - 3

SP - 399

EP - 400

JO - JAMA Cardiology

JF - JAMA Cardiology

SN - 2380-6583

IS - 5

ER -

The Treat Trial-moving ST-elevation myocardial infarction care forward, with more to do

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this